News Release

March 29, 2011

CONTACT: Greg Richter

Penn Medicine - University of Pennsylvania School of Medicine and University of Pennsylvania Health System

This release is available online at

Penn Medicine’s Center for Clinical Epidemiology and Biostatistics Receives $2 Million from CDC to Establish New Infectious Disease Research Program

PHILADELPHIA – The Centers for Disease Control and Prevention (CDC) gave the Center for Clinical Epidemiology and Biostatistics (CCEB) at the University of Pennsylvania School of Medicine $2 million over the next five years to fund research to find new ways to reduce infections in health care settings.

The CDC Prevention Epicenter program chose CCEB as one of five academic medical centers nationwide to receive the funding. This is the first year that the CCEB is included in the funding. The Penn Medicine center, led by Ebbing Lautenbach, MD, MPH, MSCE, associate professor of medicine, Infectious Diseases Division, and associate professor of Epidemiology, will focus on the use of biomarkers, such as C-reactive protein, to improve antibiotic use in intensive care unit settings.

The CDC estimates that 1 out of 20 hospitalized patients will obtain an infection during the process of receiving care for other health conditions. The CDC is distributing a total of $10 million across the five centers to combat those numbers.

“Although this program has been in existence for over 10 years, this award represents the first time that Penn will be one of the five epicenter sites across the US,” said Lautenbach. “This represents a great opportunity for us to perform not only the work proposed at the Penn site, but also to help lead a larger collaborative effort to advance the science focusing on healthcare-acquired infections.”

For more information on the 2011 CDC Epicenter awards, please read the CDC news release:


Penn Medicine is one of the world's leading academic medical centers, dedicated to the related missions of medical education, biomedical research, and excellence in patient care. Penn Medicine consists of the Raymond and Ruth Perelman School of Medicine at the University of Pennsylvania (founded in 1765 as the nation's first medical school) and the University of Pennsylvania Health System, which together form a $4.3 billion enterprise.

The Perelman School of Medicine has been ranked among the top five medical schools in the United States for the past 17 years, according to U.S. News & World Report's survey of research-oriented medical schools. The School is consistently among the nation's top recipients of funding from the National Institutes of Health, with $392 million awarded in the 2013 fiscal year.

The University of Pennsylvania Health System's patient care facilities include: The Hospital of the University of Pennsylvania -- recognized as one of the nation's top "Honor Roll" hospitals by U.S. News & World Report; Penn Presbyterian Medical Center; Chester County Hospital; Lancaster General Health; Penn Wissahickon Hospice; and Pennsylvania Hospital -- the nation's first hospital, founded in 1751. Additional affiliated inpatient care facilities and services throughout the Philadelphia region include Chestnut Hill Hospital and Good Shepherd Penn Partners, a partnership between Good Shepherd Rehabilitation Network and Penn Medicine.

Penn Medicine is committed to improving lives and health through a variety of community-based programs and activities. In fiscal year 2013, Penn Medicine provided $814 million to benefit our community.